# Peptides for energy and longevity

Source: https://aminodesk.com/goals/energy-and-longevity
Publisher: Amino Desk
Updated: 2026-11-17
Clinical review: pending

No injectable sold for energy or longevity has a controlled trial showing it works in healthy people. The closest thing to human evidence is for oral NAD+ precursors, and those results are mixed.

**The short version**

- **NAD+ injections:** a legal compounded prescription, but a recent review found no controlled outcome trials of injected or IV NAD+ for wellness.
- **MOTS-c and Epitalon:** compoundable on prescription under the October 2026 policy, with no established human dose for either.
- **SS-31:** approved only for Barth syndrome, a rare mitochondrial disease.
- **Thymosin alpha-1:** approved abroad for hepatitis B, with no lawful US route.

## Better studied

Grades describe the evidence for a compound's best-studied use, which is not always the use on this page. The summary under each name says what was actually tested. [How the grades work](https://aminodesk.com/finder).

### [Methylene blue](https://aminodesk.com/library/methylene-blue)

Grade A FDA-approved

An approved prescription drug for one rare blood condition, now sold in dropper bottles for focus. Carries a boxed warning for serotonin syndrome with SSRIs and similar drugs.

### [L-carnitine (injectable)](https://aminodesk.com/library/l-carnitine)

Grade B Mixed

Approved for carnitine deficiency and sold as weight-loss shots. Dozens of trials, mostly oral, show about 1 kg of extra weight loss; the shots themselves are untested.

### [SS-31 (elamipretide, Forzinity)](https://aminodesk.com/library/ss-31)

Grade B FDA-approved

Approved in 2025 for Barth syndrome, a rare mitochondrial disease, on a 12-patient trial that missed its main goals. Sold online for energy and longevity, which have not been tested.

### [Thymosin alpha-1](https://aminodesk.com/library/thymosin-alpha-1)

Grade B Not in the US

An immune peptide approved abroad as Zadaxin for hepatitis B. An FDA advisory committee voted 17 to 4 against allowing it to be compounded.

## Little or no human evidence

### [Glutathione (injectable)](https://aminodesk.com/library/glutathione)

Grade C Compounded

The body's main antioxidant, sold as IV drips for skin and detox. Not FDA-approved, and contaminated compounded batches sent patients to hospital in 2026.

### [Epitalon](https://aminodesk.com/library/epitalon)

Grade C 2026 policy

A four-amino-acid peptide sold for longevity and telomere effects. Legally compoundable in courses since October 2026; the human evidence is old and limited.

### [5-amino-1MQ](https://aminodesk.com/library/5-amino-1mq)

Grade D No legal route

Not a peptide. Blocks an enzyme involved in NAD+ metabolism. Striking results in obese mice, zero published human trials, and a 40-fold spread in the doses people inject.

### [SLU-PP-332](https://aminodesk.com/library/slu-pp-332)

Grade D No legal route

The "exercise pill." Mice ran 70% longer and obese mice lost weight. No human has been given it in a registered trial.

### [Pinealon](https://aminodesk.com/library/pinealon)

Grade D No legal route

A Russian three-amino-acid 'bioregulator' sold for memory and brain aging. Evidence is cell and rodent work from one research group.

### [MOTS-c](https://aminodesk.com/library/mots-c)

Grade D 2026 policy

Encoded in mitochondrial DNA and marketed for metabolism and energy. Newly compoundable, with the human evidence still to come.

### [NAD+](https://aminodesk.com/library/nad)

Grade D Compounded

A coenzyme central to cell metabolism. Oral precursors have human trials behind them; the injected and IV versions sold by clinics largely do not.

## What you can legally get

- **FDA-approved, by prescription:** [Methylene blue](https://aminodesk.com/library/methylene-blue), [SS-31 (elamipretide, Forzinity)](https://aminodesk.com/library/ss-31)
- **Compounded on prescription (long-standing):** [Glutathione (injectable)](https://aminodesk.com/library/glutathione), [NAD+](https://aminodesk.com/library/nad)
- **Compoundable on prescription under the October 2026 policy:** [Epitalon](https://aminodesk.com/library/epitalon), [MOTS-c](https://aminodesk.com/library/mots-c)
- **Depends on the form (see the page):** [L-carnitine (injectable)](https://aminodesk.com/library/l-carnitine)
- **Approved abroad, not available in the US:** [Thymosin alpha-1](https://aminodesk.com/library/thymosin-alpha-1)
- **No legal route in the US:** [5-amino-1MQ](https://aminodesk.com/library/5-amino-1mq), [SLU-PP-332](https://aminodesk.com/library/slu-pp-332), [Pinealon](https://aminodesk.com/library/pinealon)

Products sold online as "research use only" are outside every one of these routes. See [how to vet a provider](https://aminodesk.com/providers).

## Keep reading

- [NAD+ in detail](https://aminodesk.com/library/nad)
- [MOTS-c in detail](https://aminodesk.com/library/mots-c)
- [Filter all 40 compounds by goal and legal status](https://aminodesk.com/finder)

This page summarizes our compound pages. The sources for every claim are listed on each of those pages.

---
Educational information from Amino Desk (aminodesk.com), not medical advice. Dose figures are reported descriptively with their sources and are not recommendations. Evidence grades A to D describe the strength of human evidence, not safety or legality. When you use this content, cite the page URL.
